ArticleWorld journal of gastroenterology2025
Reduced recurrence rate with a targeted approach in uncomplicated appendicitis treated with endoscopic direct
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndoscopic retrograde appendicitis therapy (ERAT) offers an appendix-preserving approach; however, visual and specificity challenges persist. Conversely, endoscopic direct appendicitis therapy (EDAT) provides direct visual observation with diagnostic and therapeutic capabilities.
aimTo assess the efficacy and feasibility of EDAT and compare them with those of ERAT in uncomplicated appendicitis.
methodsIn this retrospective cohort study, patients diagnosed with uncomplicated appendicitis and treated with ERAT or EDAT between January 2021 and November 2024 were reviewed. The primary outcome was intervention success. Secondary outcomes were guidewire use, stent placement, hospitalization duration, recurrence, and endoscopic direct-view features. Outcomes were compared between groups
resultsOf 170 patients, 136 underwent EDAT and 34 ERAT. EDAT showed higher intervention success than ERAT (99.3%
conclusionEDAT was demonstrated to be a more effective and feasible approach than ERAT, with a lower overall cumulative recurrence risk and within the appendicolith subgroup. Consistent results after PSM further supported the robustness of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.